Preparation and Characterization of L-ascorbic Acid Ethosomal Formulation for Enhancement of Permeation

Ahmed Alabada, Murtadaa Mohammed
{"title":"Preparation and Characterization of L-ascorbic Acid Ethosomal Formulation for Enhancement of Permeation","authors":"Ahmed Alabada, Murtadaa Mohammed","doi":"10.37319/iqnjm.5.2.4","DOIUrl":null,"url":null,"abstract":"Background: Vesicular system is a good approach to improve hydrophilic drug permeability using phospholipids as Nanocarriers to increase lipophilicity and reduce vesicle size. L-ascorbic acid is a water soluble vitamin with antioxidant activity with poor skin permeability. Aim: The purpose of this work is to prepare LAA-containing ethosomes formulations utilizing a modified thin film hydration approach. Methods: eight formulas were prepared using different types of phospholipids (egg yolk lecithin and soya lecithin), different volumes of ethanol (2 and 3mL), and tween 80 as a surfactant. The prepared formulas (F1, F2, F3, F4, F5, F6, F7 and F8) were characterized to detect the best one regarding the physical appearance, pH, average vesicle size, polydispersity index (PDI) and entrapment efficiency. Scanning electron microscope (SEM) and transmission electron microscope (TEM) were used to evaluate the morphological properties Results: The best prepared ethosomal formula was F3 which contains (1.5g) LAA, (0.1 g) egg yolk lecithin, (2 mL) ethanol, 0.025 mL tween 80 and (q.s.10mL) of distilled water. Its average vesicle size value (176nm), PDI = 0.243, high entrapment efficiency (89.8%) and good physical stability. The morphological properties showing spherical, smooth, and devoid of drug crystalline structures.  The drug-excipient compatibility is confirmed using (FTIR, DSC and PXRD) analyses. Additionally, the Ex-vivo drug permeation investigation demonstrated that the prepared formula of LAA had flux and permeability coefficients that were two times higher than the control. Conclusions: The average vesicle size and PDI are affected by, the volume of ethanol, type of lecithin and presence of solubilizing agent.\n ","PeriodicalId":333401,"journal":{"name":"Iraqi National journal of Medicine","volume":"19 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iraqi National journal of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37319/iqnjm.5.2.4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Vesicular system is a good approach to improve hydrophilic drug permeability using phospholipids as Nanocarriers to increase lipophilicity and reduce vesicle size. L-ascorbic acid is a water soluble vitamin with antioxidant activity with poor skin permeability. Aim: The purpose of this work is to prepare LAA-containing ethosomes formulations utilizing a modified thin film hydration approach. Methods: eight formulas were prepared using different types of phospholipids (egg yolk lecithin and soya lecithin), different volumes of ethanol (2 and 3mL), and tween 80 as a surfactant. The prepared formulas (F1, F2, F3, F4, F5, F6, F7 and F8) were characterized to detect the best one regarding the physical appearance, pH, average vesicle size, polydispersity index (PDI) and entrapment efficiency. Scanning electron microscope (SEM) and transmission electron microscope (TEM) were used to evaluate the morphological properties Results: The best prepared ethosomal formula was F3 which contains (1.5g) LAA, (0.1 g) egg yolk lecithin, (2 mL) ethanol, 0.025 mL tween 80 and (q.s.10mL) of distilled water. Its average vesicle size value (176nm), PDI = 0.243, high entrapment efficiency (89.8%) and good physical stability. The morphological properties showing spherical, smooth, and devoid of drug crystalline structures.  The drug-excipient compatibility is confirmed using (FTIR, DSC and PXRD) analyses. Additionally, the Ex-vivo drug permeation investigation demonstrated that the prepared formula of LAA had flux and permeability coefficients that were two times higher than the control. Conclusions: The average vesicle size and PDI are affected by, the volume of ethanol, type of lecithin and presence of solubilizing agent.  
l -抗坏血酸溶酶体增强渗透制剂的制备与表征
背景:以磷脂为纳米载体,提高亲脂性,减小囊泡大小,是提高亲水性药物通透性的良好途径。l -抗坏血酸是一种水溶性维生素,具有抗氧化活性,但皮肤渗透性差。目的:利用改进的薄膜水合方法制备含laa的酶质体制剂。方法:以不同类型的磷脂(蛋黄卵磷脂和大豆卵磷脂)、不同体积的乙醇(2和3mL)、吐温80作为表面活性剂制备8种配方。对制备的配方(F1、F2、F3、F4、F5、F6、F7和F8)进行表征,从物理外观、pH、平均囊泡大小、多分散性指数(PDI)和包封效率等方面考察最佳配方。采用扫描电镜(SEM)和透射电镜(TEM)对其形态进行了表征。结果:制备的最佳溶酶体配方为F3,其中含有(1.5g) LAA、(0.1 g)蛋黄卵磷脂、(2 mL)乙醇、0.025 mL间80和0.05 mL蒸馏水。其平均囊泡大小值(176nm), PDI = 0.243,包封效率高(89.8%),物理稳定性好。形态特征为球形,光滑,无药物晶体结构。通过FTIR、DSC和PXRD分析,确定了其与赋形剂的配伍性。此外,体外药物渗透实验表明,制备的LAA的通量系数和渗透系数比对照高2倍。结论:乙醇体积、卵磷脂种类和增溶剂的存在对平均囊泡大小和PDI有影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信